RIA therapy is crucial for treating thyroid disorders, specifically thyroid cancer. This study aims to evaluate the efficacy of 30 mCi and 50 mCi RIA therapy doses in low-risk papillary thyroid carcinoma patients post-thyroidectomy, based on their thyroglobulin levels. In order to achieve this goal, we have carefully analyzed and evaluated the thyroglobulin levels before and after radioiodine treatment while also examining the values from different viewpoints. In our thorough analysis, we found that about 90% of study participants experienced positive outcomes, indicating a high success rate. The study shows that both RIA therapy doses effectively reduced thyroglobulin levels in low-risk papillary thyroid carcinoma patients post-thyroidectomy. This provides insights into the optimal therapy dosage for this patient group. This approach should take into consideration the differences between patients, such as absorption rate and the specific state of the patient, in order to ensure a balance between therapeutic efficacy and radioexposure.
"synopsis" may belong to another edition of this title.
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9786209264450
Seller: California Books, Miami, FL, U.S.A.
Condition: New. Seller Inventory # I-9786209264450
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9786209264450
Quantity: Over 20 available
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 80 pp. Englisch. Seller Inventory # 9786209264450
Quantity: 2 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - RIA therapy is crucial for treating thyroid disorders, specifically thyroid cancer. This study aims to evaluate the efficacy of 30 mCi and 50 mCi RIA therapy doses in low-risk papillary thyroid carcinoma patients post-thyroidectomy, based on their thyroglobulin levels. In order to achieve this goal, we have carefully analyzed and evaluated the thyroglobulin levels before and after radioiodine treatment while also examining the values from different viewpoints. In our thorough analysis, we found that about 90% of study participants experienced positive outcomes, indicating a high success rate. The study shows that both RIA therapy doses effectively reduced thyroglobulin levels in low-risk papillary thyroid carcinoma patients post-thyroidectomy. This provides insights into the optimal therapy dosage for this patient group. This approach should take into consideration the differences between patients, such as absorption rate and the specific state of the patient, in order to ensure a balance between therapeutic efficacy and radioexposure. Seller Inventory # 9786209264450
Quantity: 1 available
Seller: Books Puddle, Woodside, NY, U.S.A.
Condition: New. Seller Inventory # 26405593414
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Print on Demand. Seller Inventory # 408642201
Quantity: 4 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND. Seller Inventory # 18405593420
Quantity: 4 available
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. RIA therapy is crucial for treating thyroid disorders, specifically thyroid cancer. This study aims to evaluate the efficacy of 30 mCi and 50 mCi RIA therapy doses in low-risk papillary thyroid carcinoma patients post-thyroidectomy, based on their thyroglobulin levels. In order to achieve this goal, we have carefully analyzed and evaluated the thyroglobulin levels before and after radioiodine treatment while also examining the values from different viewpoints. In our thorough analysis, we found that about 90% of study participants experienced positive outcomes, indicating a high success rate. The study shows that both RIA therapy doses effectively reduced thyroglobulin levels in low-risk papillary thyroid carcinoma patients post-thyroidectomy. This provides insights into the optimal therapy dosage for this patient group. This approach should take into consideration the differences between patients, such as absorption rate and the specific state of the patient, in order to ensure a balance between therapeutic efficacy and radioexposure. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9786209264450
Quantity: 1 available
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -RIA therapy is crucial for treating thyroid disorders, specifically thyroid cancer. This study aims to evaluate the efficacy of 30 mCi and 50 mCi RIA therapy doses in low-risk papillary thyroid carcinoma patients post-thyroidectomy, based on their thyroglobulin levels. In order to achieve this goal, we have carefully analyzed and evaluated the thyroglobulin levels before and after radioiodine treatment while also examining the values from different viewpoints. In our thorough analysis, we found that about 90% of study participants experienced positive outcomes, indicating a high success rate. The study shows that both RIA therapy doses effectively reduced thyroglobulin levels in low-risk papillary thyroid carcinoma patients post-thyroidectomy. This provides insights into the optimal therapy dosage for this patient group. This approach should take into consideration the differences between patients, such as absorption rate and the specific state of the patient, in order to ensure a balance between therapeutic efficacy and radioexposure.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 80 pp. Englisch. Seller Inventory # 9786209264450
Quantity: 1 available